Pliant Therapeutics Inc.

NASDAQ: PLRX · Real-Time Price · USD
1.54
-0.03 (-2.22%)
At close: Aug 15, 2025, 3:59 PM
1.54
-0.32%
After-hours: Aug 15, 2025, 05:57 PM EDT

Pliant Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 2.27M n/a n/a n/a 4.84M -4.84M 248K 1.33M 1.97M 1.48M 4.99M 1.25M 2M 1.61M 1.79M 2.17M
Cost of Revenue
447K 448K 1.14M 532K 622K 513K 464K 1.04M 1.1M 1.06M 1.05M 1.03M 899K 699K 2.09M 400K n/a n/a
Gross Profit
-447K -448K 1.14M -532K -622K -513K 4.38M -2.21M -856K 271K 912K 452K 4.09M 550K -88K 1.21M 1.79M 2.17M
Operating Income
-45.59M -58.94M -53.32M -62.01M -60.64M -52.39M -47.04M -47.69M -47.33M -42.09M -37.4M -31.95M -29.64M -28.21M -24.6M -27.11M -22.9M -22.92M
Interest Income
n/a 3.57M 4.42M 5.13M 5.65M 5.88M 6.25M 6.51M 6.46M 4.86M 2.66M 1.63M 269K 111K 68K 68K 73K 63K
Pretax Income
-43.3M -56.17M -49.73M -57.76M -55.85M -46.95M -41.11M -41.49M -41.19M -37.55M -35.06M -30.61M -29.55M -28.1M -24.53M -27.05M -22.83M -22.86M
Net Income
-43.3M -56.17M -49.73M -57.76M -55.85M -46.95M -41.11M -41.49M -41.19M -28.14M -34.6M -27.95M -29.55M -27.88M -24.53M -27.05M -22.83M -22.86M
Selling & General & Admin
13.39M 15.5M 14.53M 14.26M 15.02M 15.25M 13.85M 15.35M 14.57M 14.15M 14.25M 8.82M 8.3M 8.58M 7.85M 7.67M 5.47M 6.57M
Research & Development
32.2M 43.44M 38.79M 47.75M 44.99M 36.63M 32.72M 32.34M 33M 29.27M 25.11M 24.61M 26.34M 20.88M 18.75M 21.05M 19.22M 18.53M
Other Expenses
-447K n/a n/a n/a n/a n/a 464K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
45.15M 58.94M 53.32M 62.01M 60.02M 51.88M 47.04M 47.69M 47.58M 43.43M 39.37M 33.43M 34.63M 29.46M 26.6M 28.72M 24.69M 25.09M
Interest Expense
809K 799K 834K 877K 868K 445K 321K 317K 319K 311K 317K 301K 173K n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
45.59M 58.94M 53.32M 62.01M 60.64M 52.39M 47.04M 47.69M 47.58M 43.43M 39.37M 33.43M 34.63M 29.46M 26.6M 28.72M 24.69M 25.09M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a -9.4M -455K -2.66M 269K -222K n/a -12K -30K n/a
Shares Outstanding (Basic)
61.39M 61.22M 60.54M 60.73M 60.38M 60.18M 59.9M 59.69M 59.17M 56.06M 48.78M 46.8M 36.17M 36.03M 36.02M 35.91M 35.67M 35.65M
Shares Outstanding (Diluted)
61.39M 61.22M 60.54M 60.73M 60.38M 60.18M 59.9M 59.69M 59.17M 56.06M 48.78M 46.8M 36.17M 36.12M 36.02M 35.91M 35.75M 35.65M
EPS (Basic)
-0.71 -0.92 -0.82 -0.95 -0.92 -0.78 -0.69 -0.7 -0.7 -0.5 -0.71 -0.6 -0.82 -0.77 -0.68 -0.75 -0.64 -0.64
EPS (Diluted)
-0.71 -0.92 -0.82 -0.95 -0.92 -0.78 -0.69 -0.7 -0.7 -0.5 -0.71 -0.6 -0.82 -0.77 -0.68 -0.75 -0.64 -0.64
EBITDA
-42.04M -54.92M -48.44M -56.35M -54.36M -46M -40.32M -40.13M -39.77M -36.18M -33.72M -29.59M -28.65M -27.4M -24.18M -26.73M -22.53M -22.56M
EBIT
-42.49M -55.37M -48.9M -56.89M -54.99M -46.51M -40.79M -41.17M -40.87M -37.24M -34.77M -30.61M -29.37M -28.1M -24.6M -27.11M -22.9M -22.92M
Depreciation & Amortization
447K 448K 458K 532K 622K 513K 464K 1.04M 1.1M 1.06M 1.05M 1.03M 899K 699K 2.09M 400K 400K 359K